Viral Vector GMP Manufacturing

Bringing 30 Years of Clinical & Commercial Manufacturing Experience to the Rapidly Growing Cell and Gene Therapy Market

An external image of the Avid Bioservices viral vector manufacturing facility in California, USA
Invested $75 Million into the future of Cell & Gene Therapy

We've expanded our CDMO service offering into the rapidly growing cell and gene therapy market. 

The company constructed a world-class, purpose-built 53,000 sq. ft. viral vector development and CGMP manufacturing facility in Costa Mesa, CA.

CGMP Manufacturing Capabilities

Production Train A

Suspension Culture

  • 500L Single-Use Bioreactor

Large Scale Production

  • Capable of up to 3,000L Single-Use Bioreactor and Fixed-Bed Bioreactors

Production Train B

Master & Working Cell Banking

Suspension Culture

  • 50 & 500L Platform Single-Use Bioreactors

Adherent Culture

  • Capable of up to 40CS10s or 20 HS36s Batch Sizes


  • Platform ÄKTA Chromatography Skids & TFF Systems

  • Supporting Clinical & Commercial Programs
  • Capacity up to 2,000L Vials per Session
  • Capable Filling a Variety of Vials Ranging from 2R to 50R

Purpose-Built to Reduce Process Risk

Dedicated HVAC Supply Per Suite

– Grade C Classification For Processing Suites
– Grade B Classification For Cell Banking Suite

iHP In-Suite Decontamination

SteraMist Ionized Hyrdrogen Peroxide System
– Integrated iHP System in the Viral+ Suites
– Supports Multi-Product Manufacturing
– Fully Automated – Short Cycle Time – 6 Log Kill

Additional Process Controls

– Spatial Segregation for Viral +/- Suites
– Unidirectional Flow For Viral + Suites

Close this popup.
We use cookies to improve your experience on our site. To find out more, read our Privacy Policy.